{"pmid":32080990,"pmcid":"PMC7036342","title":"Virus Isolation from the First Patient with SARS-CoV-2 in Korea.","text":["Virus Isolation from the First Patient with SARS-CoV-2 in Korea.","Novel coronavirus (SARS-CoV-2) is found to cause a large outbreak started from Wuhan since December 2019 in China and SARS-CoV-2 infections have been reported with epidemiological linkage to China in 25 countries until now. We isolated SARS-CoV-2 from the oropharyngeal sample obtained from the patient with the first laboratory-confirmed SARS-CoV-2 infection in Korea. Cytopathic effects of SARS-CoV-2 in the Vero cell cultures were confluent 3 days after the first blind passage of the sample. Coronavirus was confirmed with spherical particle having a fringe reminiscent of crown on transmission electron microscopy. Phylogenetic analyses of whole genome sequences showed that it clustered with other SARS-CoV-2 reported from Wuhan.","J Korean Med Sci","Park, Wan Beom","Kwon, Nak Jung","Choi, Su Jin","Kang, Chang Kyung","Choe, Pyoeng Gyun","Kim, Jin Yong","Yun, Jiyoung","Lee, Gir Won","Seong, Moon Woo","Kim, Nam Joong","Seo, Jeong Sun","Oh, Myoung Don","32080990"],"abstract":["Novel coronavirus (SARS-CoV-2) is found to cause a large outbreak started from Wuhan since December 2019 in China and SARS-CoV-2 infections have been reported with epidemiological linkage to China in 25 countries until now. We isolated SARS-CoV-2 from the oropharyngeal sample obtained from the patient with the first laboratory-confirmed SARS-CoV-2 infection in Korea. Cytopathic effects of SARS-CoV-2 in the Vero cell cultures were confluent 3 days after the first blind passage of the sample. Coronavirus was confirmed with spherical particle having a fringe reminiscent of crown on transmission electron microscopy. Phylogenetic analyses of whole genome sequences showed that it clustered with other SARS-CoV-2 reported from Wuhan."],"journal":"J Korean Med Sci","authors":["Park, Wan Beom","Kwon, Nak Jung","Choi, Su Jin","Kang, Chang Kyung","Choe, Pyoeng Gyun","Kim, Jin Yong","Yun, Jiyoung","Lee, Gir Won","Seong, Moon Woo","Kim, Nam Joong","Seo, Jeong Sun","Oh, Myoung Don"],"date":"2020-02-22T11:00:00Z","year":2020,"_id":"32080990","week":"20208|Feb 17 - Feb 23","doi":"10.3346/jkms.2020.35.e84","keywords":["2019 Novel Coronavirus","Culture","Korea","Microscopy, Electron","Phylogeny"],"source":"PubMed","locations":["Wuhan","South Korea","China"],"countries":["Korea, Republic of","China"],"countries_codes":["KOR|Korea, Republic of","CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1661359647387287552,"score":6.7365713,"similar":[{"pmid":32149036,"pmcid":"PMC7045880","title":"Identification of Coronavirus Isolated from a Patient in Korea with COVID-19.","text":["Identification of Coronavirus Isolated from a Patient in Korea with COVID-19.","Objectives: Following reports of patients with unexplained pneumonia at the end of December 2019 in Wuhan, China, the causative agent was identified as coronavirus (SARS-CoV-2), and the 2019 novel coronavirus disease was named COVID-19 by the World Health Organization. Putative patients with COVID-19 have been identified in South Korea, and attempts have been made to isolate the pathogen from these patients. Methods: Upper and lower respiratory tract secretion samples from putative patients with COVID-19 were inoculated onto cells to isolate the virus. Full genome sequencing and electron microscopy were used to identify the virus. Results: The virus replicated in Vero cells and cytopathic effects were observed. Full genome sequencing showed that the virus genome exhibited sequence homology of more than 99.9% with SARS-CoV-2 which was isolated from patients from other countries, for instance China. Sequence homology of SARS-CoV-2 with SARS-CoV, and MERS-CoV was 77.5% and 50%, respectively. Coronavirus-specific morphology was observed by electron microscopy in virus-infected Vero cells. Conclusion: SARS-CoV-2 was isolated from putative patients with unexplained pneumonia and intermittent coughing and fever. The isolated virus was named BetaCoV/Korea/KCDC03/2020.","Osong Public Health Res Perspect","Kim, Jeong-Min","Chung, Yoon-Seok","Jo, Hye Jun","Lee, Nam-Joo","Kim, Mi Seon","Woo, Sang Hee","Park, Sehee","Kim, Jee Woong","Kim, Heui Man","Han, Myung-Guk","32149036"],"abstract":["Objectives: Following reports of patients with unexplained pneumonia at the end of December 2019 in Wuhan, China, the causative agent was identified as coronavirus (SARS-CoV-2), and the 2019 novel coronavirus disease was named COVID-19 by the World Health Organization. Putative patients with COVID-19 have been identified in South Korea, and attempts have been made to isolate the pathogen from these patients. Methods: Upper and lower respiratory tract secretion samples from putative patients with COVID-19 were inoculated onto cells to isolate the virus. Full genome sequencing and electron microscopy were used to identify the virus. Results: The virus replicated in Vero cells and cytopathic effects were observed. Full genome sequencing showed that the virus genome exhibited sequence homology of more than 99.9% with SARS-CoV-2 which was isolated from patients from other countries, for instance China. Sequence homology of SARS-CoV-2 with SARS-CoV, and MERS-CoV was 77.5% and 50%, respectively. Coronavirus-specific morphology was observed by electron microscopy in virus-infected Vero cells. Conclusion: SARS-CoV-2 was isolated from putative patients with unexplained pneumonia and intermittent coughing and fever. The isolated virus was named BetaCoV/Korea/KCDC03/2020."],"journal":"Osong Public Health Res Perspect","authors":["Kim, Jeong-Min","Chung, Yoon-Seok","Jo, Hye Jun","Lee, Nam-Joo","Kim, Mi Seon","Woo, Sang Hee","Park, Sehee","Kim, Jee Woong","Kim, Heui Man","Han, Myung-Guk"],"date":"2020-03-10T11:00:00Z","year":2020,"_id":"32149036","week":"202011|Mar 09 - Mar 15","doi":"10.24171/j.phrp.2020.11.1.02","keywords":["COVID-19","SARS-CoV-2","coronavirus","isolation","pneumonia"],"source":"PubMed","locations":["Wuhan","South Korea","China"],"countries":["Korea, Republic of","China"],"countries_codes":["KOR|Korea, Republic of","CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1661359647799377920,"score":191.71947},{"pmid":32080991,"pmcid":"PMC7036338","title":"Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea.","text":["Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea.","As of February 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak started in China in December 2019 has been spreading in many countries in the world. With the numbers of confirmed cases are increasing, information on the epidemiologic investigation and clinical manifestation have been accumulated. However, data on viral load kinetics in confirmed cases are lacking. Here, we present the viral load kinetics of the first two confirmed patients with mild to moderate illnesses in Korea in whom distinct viral load kinetics are shown. This report suggests that viral load kinetics of SARS-CoV-2 may be different from that of previously reported other coronavirus infections such as SARS-CoV.","J Korean Med Sci","Kim, Jin Yong","Ko, Jae Hoon","Kim, Yeonjae","Kim, Yae Jean","Kim, Jeong Min","Chung, Yoon Seok","Kim, Heui Man","Han, Myung Guk","Kim, So Yeon","Chin, Bum Sik","32080991"],"abstract":["As of February 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak started in China in December 2019 has been spreading in many countries in the world. With the numbers of confirmed cases are increasing, information on the epidemiologic investigation and clinical manifestation have been accumulated. However, data on viral load kinetics in confirmed cases are lacking. Here, we present the viral load kinetics of the first two confirmed patients with mild to moderate illnesses in Korea in whom distinct viral load kinetics are shown. This report suggests that viral load kinetics of SARS-CoV-2 may be different from that of previously reported other coronavirus infections such as SARS-CoV."],"journal":"J Korean Med Sci","authors":["Kim, Jin Yong","Ko, Jae Hoon","Kim, Yeonjae","Kim, Yae Jean","Kim, Jeong Min","Chung, Yoon Seok","Kim, Heui Man","Han, Myung Guk","Kim, So Yeon","Chin, Bum Sik"],"date":"2020-02-22T11:00:00Z","year":2020,"_id":"32080991","week":"20208|Feb 17 - Feb 23","doi":"10.3346/jkms.2020.35.e86","keywords":["2019-nCoV","COVID-19","Coronavirus","SARS-CoV-2","Viral Load Kinetics"],"source":"PubMed","locations":["South Korea","China"],"countries":["Korea, Republic of","China"],"countries_codes":["KOR|Korea, Republic of","CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1661359647399870464,"score":98.1396},{"pmid":32165386,"title":"Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal.","text":["Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal.","A complete genome sequence was obtained for a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain isolated from an oropharyngeal swab specimen of a Nepalese patient with coronavirus disease 2019 (COVID-19), who had returned to Nepal after traveling to Wuhan, China.","Microbiol Resour Announc","Sah, Ranjit","Rodriguez-Morales, Alfonso J","Jha, Runa","Chu, Daniel K W","Gu, Haogao","Peiris, Malik","Bastola, Anup","Lal, Bibek Kumar","Ojha, Hemant Chanda","Rabaan, Ali A","Zambrano, Lysien I","Costello, Anthony","Morita, Kouichi","Pandey, Basu Dev","Poon, Leo L M","32165386"],"abstract":["A complete genome sequence was obtained for a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain isolated from an oropharyngeal swab specimen of a Nepalese patient with coronavirus disease 2019 (COVID-19), who had returned to Nepal after traveling to Wuhan, China."],"journal":"Microbiol Resour Announc","authors":["Sah, Ranjit","Rodriguez-Morales, Alfonso J","Jha, Runa","Chu, Daniel K W","Gu, Haogao","Peiris, Malik","Bastola, Anup","Lal, Bibek Kumar","Ojha, Hemant Chanda","Rabaan, Ali A","Zambrano, Lysien I","Costello, Anthony","Morita, Kouichi","Pandey, Basu Dev","Poon, Leo L M"],"date":"2020-03-14T11:00:00Z","year":2020,"_id":"32165386","week":"202011|Mar 09 - Mar 15","doi":"10.1128/MRA.00169-20","source":"PubMed","locations":["Nepal","Nepalese","Wuhan","swab","China"],"countries":["Nepal","China"],"countries_codes":["NPL|Nepal","CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1661359647929401345,"score":92.23056},{"pmid":32179125,"title":"Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?","text":["Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?","BACKGROUND: An ongoing epidemic of respiratory diseases caused by a novel coronavirus (COVID 2019, SARS-CoV2) started in Wuhan, Hubei, in China at the end of December 2019. The French government decided to repatriate the 337 French nationals living in Wuhan and place them in quarantine in their home country. We decided to test them all for SARS-Cov2 twice in order to reduce anxiety among the population and decision-makers. METHODS: We investigated the presence of SARS-CoV-19 in asymptomatic carriers by testing all repatriated patients within the first 24h of their arrival in France and at day 5. Viral RNA was extracted from pooled nasal and oropharyngeal swab fluids or sputum in the absence of nasal/oropharyngeal swabs. Detection of SARS-CoV-2 RNA was then carried out using several real-time reverse transcription (RT)-PCR assays. RESULTS: We tested 337 passengers at day 0 and day 5. All the tests for SARS-CoV2 were negative. By optimising the sampling process, sending samples sequentially and reducing the time-scale for biological analysis, we were able to test the samples within 5h (including sampling, shipment and biological tests). CONCLUSION: Optimising our procedures reduces anxiety and reassures the population and decision makers.","Travel Med Infect Dis","Lagier, Jean Christophe","Colson, Philippe","Tissot Dupont, Herve","Salomon, Jerome","Doudier, Barbara","Aubry, Camille","Gouriet, Frederique","Baron, Sophie","Dudouet, Pierre","Flores, Remi","Ailhaud, Lucie","Gautret, Philippe","Parola, Philippe","La Scola, Bernard","Raoult, Didier","Brouqui, Philippe","32179125"],"abstract":["BACKGROUND: An ongoing epidemic of respiratory diseases caused by a novel coronavirus (COVID 2019, SARS-CoV2) started in Wuhan, Hubei, in China at the end of December 2019. The French government decided to repatriate the 337 French nationals living in Wuhan and place them in quarantine in their home country. We decided to test them all for SARS-Cov2 twice in order to reduce anxiety among the population and decision-makers. METHODS: We investigated the presence of SARS-CoV-19 in asymptomatic carriers by testing all repatriated patients within the first 24h of their arrival in France and at day 5. Viral RNA was extracted from pooled nasal and oropharyngeal swab fluids or sputum in the absence of nasal/oropharyngeal swabs. Detection of SARS-CoV-2 RNA was then carried out using several real-time reverse transcription (RT)-PCR assays. RESULTS: We tested 337 passengers at day 0 and day 5. All the tests for SARS-CoV2 were negative. By optimising the sampling process, sending samples sequentially and reducing the time-scale for biological analysis, we were able to test the samples within 5h (including sampling, shipment and biological tests). CONCLUSION: Optimising our procedures reduces anxiety and reassures the population and decision makers."],"journal":"Travel Med Infect Dis","authors":["Lagier, Jean Christophe","Colson, Philippe","Tissot Dupont, Herve","Salomon, Jerome","Doudier, Barbara","Aubry, Camille","Gouriet, Frederique","Baron, Sophie","Dudouet, Pierre","Flores, Remi","Ailhaud, Lucie","Gautret, Philippe","Parola, Philippe","La Scola, Bernard","Raoult, Didier","Brouqui, Philippe"],"date":"2020-03-18T11:00:00Z","year":2020,"_id":"32179125","week":"202012|Mar 16 - Mar 22","doi":"10.1016/j.tmaid.2020.101624","keywords":["Anxiety","COVID-19","Coronavirus","Early","Quarantine","Rapid testing"],"source":"PubMed","locations":["Hubei","France","China","French","Wuhan"],"countries":["China","France"],"countries_codes":["CHN|China","FRA|France"],"topics":["Diagnosis"],"weight":1,"_version_":1661542091990237184,"score":90.46873},{"pmid":32104911,"title":"Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.","text":["Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.","To investigate the evolutionary history of the recent outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China, a total of 70 genomes of virus strains from China and elsewhere with sampling dates between 24 December 2019 and 3 February 2020 were analyzed. To explore the potential intermediate animal host of the SARS-CoV-2 virus, we reanalyzed virome data sets from pangolins and representative SARS-related coronaviruses isolates from bats, with particular attention paid to the spike glycoprotein gene. We performed phylogenetic, split network, transmission network, likelihood-mapping, and comparative analyses of the genomes. Based on Bayesian time-scaled phylogenetic analysis using the tip-dating method, we estimated the time to the most recent common ancestor and evolutionary rate of SARS-CoV-2, which ranged from 22 to 24 November 2019 and 1.19 to 1.31 x 10(-3) substitutions per site per year, respectively. Our results also revealed that the BetaCoV/bat/Yunnan/RaTG13/2013 virus was more similar to the SARS-CoV-2 virus than the coronavirus obtained from the two pangolin samples (SRR10168377 and SRR10168378). We also identified a unique peptide (PRRA) insertion in the human SARS-CoV-2 virus, which may be involved in the proteolytic cleavage of the spike protein by cellular proteases, and thus could impact host range and transmissibility. Interestingly, the coronavirus carried by pangolins did not have the RRAR motif. Therefore, we concluded that the human SARS-CoV-2 virus, which is responsible for the recent outbreak of COVID-19, did not come directly from pangolins.","J Med Virol","Li, Xingguang","Zai, Junjie","Zhao, Qiang","Nie, Qing","Li, Yi","Foley, Brian T","Chaillon, Antoine","32104911"],"abstract":["To investigate the evolutionary history of the recent outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China, a total of 70 genomes of virus strains from China and elsewhere with sampling dates between 24 December 2019 and 3 February 2020 were analyzed. To explore the potential intermediate animal host of the SARS-CoV-2 virus, we reanalyzed virome data sets from pangolins and representative SARS-related coronaviruses isolates from bats, with particular attention paid to the spike glycoprotein gene. We performed phylogenetic, split network, transmission network, likelihood-mapping, and comparative analyses of the genomes. Based on Bayesian time-scaled phylogenetic analysis using the tip-dating method, we estimated the time to the most recent common ancestor and evolutionary rate of SARS-CoV-2, which ranged from 22 to 24 November 2019 and 1.19 to 1.31 x 10(-3) substitutions per site per year, respectively. Our results also revealed that the BetaCoV/bat/Yunnan/RaTG13/2013 virus was more similar to the SARS-CoV-2 virus than the coronavirus obtained from the two pangolin samples (SRR10168377 and SRR10168378). We also identified a unique peptide (PRRA) insertion in the human SARS-CoV-2 virus, which may be involved in the proteolytic cleavage of the spike protein by cellular proteases, and thus could impact host range and transmissibility. Interestingly, the coronavirus carried by pangolins did not have the RRAR motif. Therefore, we concluded that the human SARS-CoV-2 virus, which is responsible for the recent outbreak of COVID-19, did not come directly from pangolins."],"journal":"J Med Virol","authors":["Li, Xingguang","Zai, Junjie","Zhao, Qiang","Nie, Qing","Li, Yi","Foley, Brian T","Chaillon, Antoine"],"date":"2020-02-28T11:00:00Z","year":2020,"_id":"32104911","week":"20209|Feb 24 - Mar 01","doi":"10.1002/jmv.25731","keywords":["COVID-19","SARS-CoV-2","TMRCA","cross-species transmission","evolutionary rate","potential intermediate animal host"],"source":"PubMed","locations":["Bayesian","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Transmission"],"weight":1,"_version_":1661359647537233921,"score":90.18744}]}